HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unilever Vows No GSK-Sized Ventures For Foreseeable Future, Commits To Existing Brands In 2022

Executive Summary

Opening the company’s fiscal 2021 full-year earnings call, Unilever leadership assured investors it will not make any GSK-sized offers in the foreseeable future as it commits to organic growth and reshaping its portfolio more surgically through bolt-on deals and selective disposals.

You may also be interested in...



Unilever To Slim Down Further With Ice Cream Separation

Unilever's ‘Fewer Things Better’ Growth Action Plan is in motion as the London-based company announces plans to separate out its Ice Cream division to accelerate growth and achieve cost savings of around €800m over the next three years.

Private Equity Firm Yellow Wood Plans Refresh For Suave Beauty, Hair Products In US, Canada

Suave hair and beauty brand getting new home in US and Canada at private equity firm Yellow Wood Partners, which plans to grow line through innovation, marketing and distribution. Unilever maintains ownership in other regions.

Unilever’s Living Proof To Provide First Look At Revieve AI Haircare Advisor

Living Proof will be first out of the gates with the new AI Haircare Advisor from beauty tech firm Revieve. The digital tool is designed to go beyond modeling hair color and tone effects, leveraging consumer input and selfie to match with hair cleansing, conditioning, and styling products.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152203

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel